Home›Quetiapine

Quetiapine

Also known as: Seroquel

Atypical Antipsychotic

Route: Oral

Check Quetiapine Interactions →
14 interactions on record⛔ Black Box Warning

Quetiapine has 14 known drug interactions based on U.S. FDA drug labeling data. 10 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Alcohol, Carbamazepine, Indinavir. Patients taking Quetiapine should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
14
Major
10
Moderate
4

Major (10)

  • Quetiapine + Alcohol— Potentiates cognitive and motor effects of quetiapine. Alcoholic beverages should be limited while taking quetiapine.
  • Quetiapine + Carbamazepine— CYP3A4 inducer decreases quetiapine exposure; dose adjustment of quetiapine necessary.
  • Quetiapine + Indinavir— CYP3A4 inhibitor increases quetiapine exposure; dose reduction of quetiapine necessary.
  • Quetiapine + Itraconazole— CYP3A4 inhibitor increases quetiapine exposure; dose reduction of quetiapine necessary.
  • Quetiapine + Ketoconazole— Strong CYP3A4 inhibitor significantly increases quetiapine exposure; reduce quetiapine dose to one sixth of original dos…
  • Quetiapine + Nefazodone— CYP3A4 inhibitor increases quetiapine exposure; dose reduction of quetiapine necessary.
  • Quetiapine + Phenytoin— Potent CYP3A4 inducer increases quetiapine clearance 5-fold; increase quetiapine dose up to 5-fold during chronic use an…
  • Quetiapine + Rifampin— Potent CYP3A4 inducer increases quetiapine clearance; increase quetiapine dose up to 5-fold during chronic use and reduc…
  • Quetiapine + Ritonavir— Strong CYP3A4 inhibitor significantly increases quetiapine exposure; reduce quetiapine dose to one sixth of original dos…
  • Quetiapine + St. John'S Wort— Potent CYP3A4 inducer increases quetiapine clearance; increase quetiapine dose up to 5-fold during chronic use and reduc…

Moderate (4)

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations